Dilip Shanghvi was born on Saturday, October 1, 1955, in Amreli, Gujarat, India (age 68; as of 2023). He grew up in the Brabazar area of Kolkata, living with his parents. He attended JJ Ajmera High School in Kolkata. Shanghvi received his Bachelor of Commerce degree from Bhawanipur Educational Society College, University of Calcutta.
appearance
Height (approximately): 5′ 5″
Hair Color: Salt & Pepper
Eye color: black
family
Dileep was born in Kolkata to a Gujarati Hindu family.
Parents and siblings
Dilip Shanghvi is the son of businessmen Shantilal N. Shanghvi and Kumud S. Shanghvi. Not much information is available about his siblings.
wife and children
Dilip Shanghvi married Vibha Shanghvi. The couple has a son Aalok Shanghvi and a daughter Vidhi Shanghvi. Both of their children work in the family business, Sun Pharmaceuticals.
religion
He believes in Hinduism.
Profession
Dilip Shanghvi started his career in the wholesale business of generic drugs with his father. His entrepreneurial spirit and determination led him to produce his own medicines rather than sell other people’s products. In 1982, 27-year-old Dilip founded Sun Pharmaceutical Industries Ltd. The company assembles it in Vapi, Gujarat, India. In the early days of Sun Pharma, Dilip faced several challenges; however, he persevered and focused on building a reputation for producing quality and affordable medicines. He led Sun Pharma to growth and success through strategic acquisitions and product development, becoming its “Chairman” and “General Manager”. In 2021, Dileep resigned as SPARC’s managing director and took up his role as its chairman and non-executive director.
acquisition
Sun Pharma has been involved in several major acquisitions to expand its business and product portfolio, and made its first overseas acquisition when it acquired Caraco Pharmaceutical Laboratories in Detroit. Some other noteworthy acquisitions include:
Taro Pharmaceutical Industry
In 2007, Sun Pharma acquired a controlling stake in the Israeli company Taro Pharmaceutical Industries. Taro engages in the development, manufacturing and marketing of a variety of prescription and over-the-counter products.
Ranbaxy Laboratories
In 2014, Sun Pharmaceutical acquired about $4 billion from Ranbaxy Laboratories, one of India’s largest pharmaceutical companies. The acquisition enables Sun Pharma to strengthen its position in the global pharmaceutical market and gain access to a wider range of products.
Daiichi Sankyo
In June 2008, Japan’s Daiichi Sankyo Pharmaceutical Company spent a huge amount of money to acquire a majority stake in the Indian pharmaceutical company Ranbaxy Laboratories. However, in 2014, Daiichi Sankyo sold its entire stake in Ranbaxy to Sun Pharmaceutical.
other indulgences
In January 2018, Dilip Shanghvi was appointed by the Indian government to the 21-member Central Board Committee of the Reserve Bank of India. He was appointed Chairman of the Board of Trustees of IIT Bombay. He also served as a trustee of the Oxford University Rhodes Scholarship Program in 2017.
dispute
Insider trading case
Sun Pharmaceutical faced an insider trading case in 2017, which involved some of the company’s executives and related parties suspected of insider trading.
Whistleblower complains to SEBI
According to a whistleblower complaint filed with the Securities and Exchange Board of India (SEBI), an employee of Sun Pharma and one of its executives were involved in multiple transactions, citing corporate governance violations.
Awards, Honors, Achievements
- He was awarded the Padma Shri by the Government of India in 2016.
- CNN-IBN India Business of the Year Awards 2011.
net worth
Shanghvi’s net worth is $14.3 billion; as of 2021.
Favorites
- Cuisine: South Indian
- Restaurants: Mysore Cafe and Madras Cafe in Mumbai
Facts/Trivia
- In 2019, journalist and author Soma Das wrote a biopic on Dilip Shanghvi titled The Reluctant Billionaire.
Categories: Biography
Source: HIS Education